Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
Open accessThe DOI matches its Crossref record.
Abstract
Structure-activity studies demonstrate that galanin fragments 1-15 and 2-29 are fully active, whereas fragment 3-29 has been reported to be inactive, in a number of different in vivo models. M15, a chimeric peptide comprising galanin 1-13 and substance P5-11, has recently been found to be a potent galanin antagonist. Direct effects of galanin at the level of the pituitary have been defined, yet, paradoxically, a number of studies have been unable to demonstrate galanin binding to an anterior pituitary receptor. Porcine galanin stimulated prolactin release from dispersed rat anterior pituitary cells up to 180% +/- 12% (mean +/- SEM) of control secretion. The addition of a specific galanin antiserum caused a profound inhibition of basal prolactin release, maximal inhibition being 12% +/- 0.5% of control secretion. Addition of M15 produced no effect on basal or galanin-stimulated prolactin release. Galanin fragment 3-29 was fully active when compared to galanin 1-29. Fragments 5-29 and 8-29 stimulated prolactin release to a lesser extent and galanin 1-15, 10-29, and 20-29 had no significant prolactin-releasing activity. Using [mono(125I)iodo-Tyr26]galanin or porcine 125I-labeled Bolton-Hunter [mono(125I)iodo-Lys25]galanin, no anterior pituitary membrane binding was observed. In contrast, 125I-labeled Bolton-Hunter N-terminally labeled galanin allowed characterization of a single high-affinity anterior pituitary galanin receptor with a Kd of 4.4 +/- 0.34 nM and a Bmax of 79 +/- 8.3 fmol/mg of protein. The IC50 for porcine galanin was 0.51 +/- 0.04 nM but for M15 was in excess of 10 microM. Galanin 3-29 fully displaced the label with an IC50 of 0.96 +/- 0.7 nM. The IC50 for galanin 5-29 was 200 nM, whereas 8-29 and 1-15 were > 1 microM. Galanin 10-29 and 20-29 failed to displace the label. These data suggest the presence of a high-affinity pituitary galanin receptor, designated GAL-R2, in which region 3-10 and amino acid 25 are crucial for membrane binding and biological activity, in contrast to the known gut/brain galanin receptor (designated GAL-R1). A number of tissues known to bind or respond to galanin were screened. GAL-R2 would appear to be expressed only in the anterior pituitary and hypothalamus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457
Pooga, M., Soomets, U., Hällbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J.-X., Xu, X.-J., Wiesenfeld-Hallin, Z., et al. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-857 · Cited by 574
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Branchek, T. A., Smith, K. E., Gerald, C., & Walker, M. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01446-2 · Cited by 496
LANG, R., GUNDLACH, A., & KOFLER, B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.009 · Cited by 376
Molecular cloning of a functional human galanin receptor.
Habert-Ortoli, E., Amiranoff, B., Loquet, I., Laburthe, M., & Mayaux, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9780 · Cited by 340
Lang, R., Gundlach, A. L., Holmes, F. E., Hobson, S. A., Wynick, D., Hökfelt, T., & Kofler, B. (2015) · Pharmacological Reviews · doi:10.1124/pr.112.006536 · Cited by 327
Self-citationDistribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues
Waters, S. M., & Krause, J. E. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00407-8 · Cited by 278
Cloned Human and Rat Galanin GALR3 Receptors
Smith, K. E., Walker, M. W., Artymyshyn, R., Bard, J., Borowsky, B., Tamm, J. A., Yao, W.-J., Vaysse, P. J.-J., Branchek, T. A., Gerald, C., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23321 · Cited by 258
Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus
Kinney, G. A., Emmerson, P. J., & Miller, R. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03489.1998 · Cited by 81
“In addition, the existence of other galanin receptors has been inferred from binding and functional studies ( Wynick et al., 1993; Gu et al., 1995; Valkna et al., 1995).”
BackgroundInfluentialGalanin-R1 receptor in anterior and mid-hypothalamus: Distribution and regulation
Landry, M., �MAN, K., & H�kfelt, T. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980928)399:3<321::aid-cne3>3.0.co;2-2 · Cited by 62
Metadata
- Authors
- Wynick, D., Smith, D. M., Ghatei, M., Akinsanya, K., Bhogal, R., Purkiss, P., Byfield, P., Yanaihara, N., & Bloom, S. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-05
- Volume
- 90
- Issue
- 9
- Pages
- 4231-4235
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1991729378
- Cited by
- 125
- References
- 0
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.